The largest database of trusted experimental protocols

3 protocols using colistin sulfate

1

Antimicrobial Resistance Profiling of Diarrheagenic E. coli

Check if the same lab product or an alternative is used in the 5 most similar protocols
Thirty-one (31) diarrheagenic Eschericia coli (DEC) were subjected to the antimicrobial susceptibility testing. It was carried out by disk diffusion method on Müller-Hinton agar (Liofilchem, Italy) according to the recommendations of the European Committee on Antimicrobial Susceptibility Testing (EUCAST) [10 ]. After depositing the antibiotics, the plates were incubated at +37 °C for 18–24 h. The diameters of the antibiotic sensitivity halos were recorded according to the recommendations of EUCAST. Intermediary (I) susceptibility of pathovars was classified as resistant (R). According to EUCAST recommendations on antibiotics used in case of infection with enterobacteria and in view of the multidrug resistance observed in recent years, 19 antibiotics divided into 7 different families were tested. These include amoxicillin (25 µg), amoxicillinclavulanic acid (20/10 µg), ceftriaxone (30 µg), cefotaxime (30 µg), cefepime (30 – g), cefixime (10 µg), piperacillin (75 µg), piperacillintazobactam (100 +10 µg), imipenem (10 µg), tetracycline (30 µg), chloramphenicol (30 µg), trimethoprim–sulfametoxazole (1.25 ± 23.75 µg), aztreonam (30 µg), colistin sulfate (50 µg), ciprofloxacin (5 µg), nalidixic acid (30 µg), gentamycin (15 µg), netilmicin (10 µg), and tobramycin (10 µg) (Bio-Rad, France).
+ Open protocol
+ Expand
2

Antibiotic Susceptibility Profiling of Pathogens

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibiotic susceptibility was determined on Mueller-Hinton agar using the standard disc diffusion procedure as described by the European Committee of Antimicrobial Susceptibility Testing (EUCAST) [19] . Nineteen antibiotics belonging to 7 different families were tested : amoxicillin (25 µg), amoxicillin-clavulanic acid (20/10 µg), ceftriaxone (30 µg), cefotaxime (30 µg), cefepime (30 µg), cefixime (10 µg), piperacillin (75 µg), piperacillin-tazobactam (100 + 10 µg), imipenem (10 µg), tetracycline (30 µg), chloramphenicol (30 µg), trimethoprim-sulfametoxazole (1.25 ± 23.75 µg), aztreonam (30 µg), colistin sulfate (50 µg), ciprofloxacin (5 µg), nalidixic acid (30 µg), gentamycin (15 µg), netilmicin (10 µg) and tobramycin (10 µg) (Bio-Rad, France). The diameters of the antibiotic sensitivity halos were recorded according to the recommendations of EUCAST. Intermediary (I) susceptibility of pathovars was classified as resistant (R). A double synergy test was used for ESBL-producing strains testing. This consisted of placing discs (2-3 cm diameter) of ceftriaxone and cefotaxime around an amoxicillin-clavulanic acid disc on the bacterial plate.
+ Open protocol
+ Expand
3

Antibiotic Susceptibility Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibiotic susceptibility was determined on Mueller-Hinton agar (Liofilchem, Italy) using the standard disc diffusion procedure as described by the European Committee of Antimicrobial Susceptibility Testing (EUCAST) 18 . Nineteen antibiotics belonging to 7 different families (Table 2) were tested : amoxicillin (25 µg), amoxicillin-clavulanic acid (20/10 µg), ceftriaxone (30 µg), cefotaxime (30 µg), cefepime (30 µg), cefixime (10 µg), piperacillin (75 µg), piperacillin-tazobactam (100 +10 µg), imipenem (10 µg), tetracycline (30 µg), chloramphenicol (30 µg), trimethoprimsulfametoxazole (1.25 ± 23.75 µg), aztreonam (30 µg), colistin sulfate (50 µg), ciprofloxacin (5 µg), nalidixic acid (30 µg), gentamicin (15 µg), netilmicin (10 µg) and tobramycin (10 µg) (Bio-Rad, France). The diameters of the antibiotic susceptibility halos were recorded according to the recommendations of EUCAST. Intermediate (I) susceptibility of pathovars was classified as resistant (R).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!